Key Details of the Grant:

  • The Nomination and Remuneration Committee (NRC) approved the grant at its meeting held on July 22, 2026.
  • The meeting commenced at 9:45 am IST and concluded at 10:40 am IST.
  • A total of 8,400 equity shares are covered by these options.
  • Each option carries the right to apply for and be allotted 1 (one) equity share.
  • The face value of each share is Rs. 10/-.
  • The exercise price for the eligible employees is Rs. 10/-.

Vesting and Exercise Conditions:

  • Options vested as on the date of the announcement: Nil.
  • The vesting schedule is set for after the Annual General Meeting for the Financial Year 2028-29.
  • Vesting is subject to the achievement of performance criteria as decided by the NRC and the continuation of employment.
  • Once vested, options must be exercised within 4 years from the date of vesting. Any vested options not exercised within this period shall lapse.
  • Options exercised as of the announcement date: NIL.
  • Money realized by exercise of options: NIL.
  • The total number of shares arising from the exercise of options: NIL.

Significant Terms:

  • The scheme is in terms of the SEBI (SBEB) Regulations, 2021.
  • The maximum number of options an Option Grantee is entitled to is 157,383 options.
  • There have been no subsequent changes, cancellations, or exercises of these options reported (NA).
  • Diluted EPS calculation is not applicable as options are yet to be exercised.

Compliance and Disclosure:

  • The disclosure is made in accordance with Regulation 30 of SEBI LODR and SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023.
  • The intimation has been uploaded on the company's website at www.galaxysurfactants.com.

Additional Announcements:

This filing contains no additional corporate announcements beyond the ESOP grant details.